Skip to main content
Equibles

Andrew Stewart

Analyst

Equibles does not estimate personal net worth.

About Andrew Stewart

Andrew Stewart has spoken on 1 earnings call across 1 company, most recently for Bausch & Lomb Corp on February 18, 2026. The companies whose calls Andrew Stewart spoke on are classified in the Healthcare sector.

Andrew Stewart on recent calls

“Mybo performance in 2025 was exceptional, with 113% year-over-year prescription growth that generated $316 million in revenue. We hit a significant milestone on January 2nd, crossing the $2 million prescription mark.”
Bausch & Lomb Corp Q4 FY2025 Earnings Call ·

Company network

Recent activity